On 6 January, an international team of researchers from the European Prevention of Alzheimer's Dementia (EPAD) project published a scientific article in the journal Alzheimer's Research & Therapy. In the published paper, scientists investigated whether common Alzheimer’s disease (AD)-related factors predict trial-ready cohort participation and amyloid status across different prescreen settings. The analysis included participants from four cohorts linked to the EPAD Registry (i.e. 16,877 participants with an average age of 64 years). The open access publication is available here: https://doi.org/10.1186/s13195-019-0576-y
More information about the project and the availability of the data can be found at: ep-ad.org/. The EPAD project has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 115736, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contribution.
